Literature DB >> 9222970

Identification of a recombination event narrowing the Lafora disease gene region.

L O Maddox1, M Descartes, J Collins, J Keating, S Rosenfeld, C Palmer, A J Carroll, R Kuzniecky.   

Abstract

Patients affected with progressive myoclonus epilepsy of the Lafora type present during late adolescence with a characteristic EEG pattern and Lafora bodies seen on skin biopsy. The critical region for the Lafora gene has been localised to chromosome 6q24 flanked by the dinucleotide repeat markers D6S292 and D6S420. This study for linkage of markers from the candidate gene region was performed in a previously unpublished family affected with Lafora disease. EEG and skin biopsy evaluation for Lafora bodies were performed on five of eight family members followed for seizure activity. Haplotype and linkage analysis of DNA from five family members were carried out using the nine dinucleotide repeat markers reported in the common region of homozygosity by Serratosa et al in 1995. The present study of an additional family affected by Lafora disease has narrowed the 17 cM critical region for the Lafora disease gene on chromosome 6q24 to a 4 cM region flanked by markers D6S308 and D6S311.

Entities:  

Mesh:

Year:  1997        PMID: 9222970      PMCID: PMC1051002          DOI: 10.1136/jmg.34.7.590

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  8 in total

1.  Linkage studies in progressive myoclonus epilepsy: Unverricht-Lundborg and Lafora's diseases.

Authors:  A E Lehesjoki; M Koskiniemi; M Pandolfo; A Antonelli; M Kyllerman; J Wahlström; A Nergårdh; M Burmeister; P Sistonen; R Norio
Journal:  Neurology       Date:  1992-08       Impact factor: 9.910

2.  The 1993-94 Généthon human genetic linkage map.

Authors:  G Gyapay; J Morissette; A Vignal; C Dib; C Fizames; P Millasseau; S Marc; G Bernardi; M Lathrop; J Weissenbach
Journal:  Nat Genet       Date:  1994-06       Impact factor: 38.330

3.  Studies in myoclonus epilepsy (Lafora body form). I. Isolation and preliminary characterization of Lafora bodies in two cases.

Authors:  S Yokoi; J Austin; F Witmer; M Sakai
Journal:  Arch Neurol       Date:  1968-07

4.  Studies in myoclonus epilepsy (Lafora body form). II. Polyglucosans in the systemic deposits of myoclonus epilepsy and in corpora amylacea.

Authors:  M Sakai; J Austin; F Witmer; L Trueb
Journal:  Neurology       Date:  1970-02       Impact factor: 9.910

5.  Sweat gland duct cells in Lafora disease: diagnosis by skin biopsy.

Authors:  S Carpenter; G Karpati
Journal:  Neurology       Date:  1981-12       Impact factor: 9.910

6.  Axilla skin biopsy: a reliable test for the diagnosis of Lafora's disease.

Authors:  H L Busard; A A Gabreëls-Festen; W O Renier; F J Gabreëls; A M Stadhouders
Journal:  Ann Neurol       Date:  1987-06       Impact factor: 10.422

7.  Strategies for multilocus linkage analysis in humans.

Authors:  G M Lathrop; J M Lalouel; C Julier; J Ott
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

8.  The gene for progressive myoclonus epilepsy of the Lafora type maps to chromosome 6q.

Authors:  J M Serratosa; A V Delgado-Escueta; I Posada; S Shih; I Drury; J Berciano; J A Zabala; M C Antúnez; R S Sparkes
Journal:  Hum Mol Genet       Date:  1995-09       Impact factor: 6.150

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.